These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

70 related items for PubMed ID: 2250912

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Two rearranged MET alleles in MNNG-HOS cells reveal the orientation of MET on chromosome 7 to other markers tightly linked to the cystic fibrosis locus.
    Park M, Testa JR, Blair DG, Parsa NZ, Vande Woude GF.
    Proc Natl Acad Sci U S A; 1988 Apr; 85(8):2667-71. PubMed ID: 3282234
    [Abstract] [Full Text] [Related]

  • 4. Characterization of a c-met proto-oncogene activated in human xeroderma pigmentosum cells after treatment with N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
    Michelin S, Daya-Grosjean L, Sureau F, Saïd S, Sarasin A, Suárez HG.
    Oncogene; 1993 Jul; 8(7):1983-91. PubMed ID: 8510940
    [Abstract] [Full Text] [Related]

  • 5. TRK-T1 is a novel oncogene formed by the fusion of TPR and TRK genes in human papillary thyroid carcinomas.
    Greco A, Pierotti MA, Bongarzone I, Pagliardini S, Lanzi C, Della Porta G.
    Oncogene; 1992 Feb; 7(2):237-42. PubMed ID: 1532241
    [Abstract] [Full Text] [Related]

  • 6. Activation of the met oncogene in the human MNNG-HOS cell line involves a chromosomal rearrangement.
    Tempest PR, Reeves BR, Spurr NK, Rance AJ, Chan AM, Brookes P.
    Carcinogenesis; 1986 Dec; 7(12):2051-7. PubMed ID: 3779899
    [Abstract] [Full Text] [Related]

  • 7. Lack of rearranged Tpr-met mRNA expression in human gastric cancer cell lines and gastric mucosa and carcinoma.
    Osaki M, Miyata H, Hayashi A, Gomyo Y, Tatebe S, Ito H.
    Anticancer Res; 1996 Dec; 16(5A):2881-4. PubMed ID: 8917402
    [Abstract] [Full Text] [Related]

  • 8. Autophosphorylation modulates the kinase activity and oncogenic potential of the Met receptor tyrosine kinase.
    Rodrigues GA, Park M.
    Oncogene; 1994 Jul; 9(7):2019-27. PubMed ID: 8208547
    [Abstract] [Full Text] [Related]

  • 9. TPR-MET oncogenic rearrangement: detection by polymerase chain reaction amplification of the transcript and expression in human tumor cell lines.
    Soman NR, Wogan GN, Rhim JS.
    Proc Natl Acad Sci U S A; 1990 Jan; 87(2):738-42. PubMed ID: 2300559
    [Abstract] [Full Text] [Related]

  • 10. Chromosome 1 rearrangements involving the genes TPR and NTRK1 produce structurally different thyroid-specific TRK oncogenes.
    Greco A, Miranda C, Pagliardini S, Fusetti L, Bongarzone I, Pierotti MA.
    Genes Chromosomes Cancer; 1997 Jun; 19(2):112-23. PubMed ID: 9172002
    [Abstract] [Full Text] [Related]

  • 11. Tumorigenicity assay of the human mammary carcinoma cell line MCF-7.
    Marics I, Adelaide J, Rosnet O, Planche J, Pirisi V, Birnbaum D.
    Anticancer Res; 1989 Jun; 9(6):1627-31. PubMed ID: 2560622
    [Abstract] [Full Text] [Related]

  • 12. Molecular cloning of the breakpoint region on chromosome 6 in cutaneous malignant melanoma: evidence for deletion in the c-myb locus and translocation of a segment of chromosome 12.
    Dasgupta P, Linnenbach AJ, Giaccia AJ, Stamato TD, Reddy EP.
    Oncogene; 1989 Oct; 4(10):1201-5. PubMed ID: 2677917
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Identification of tyrosine 489 in the carboxy terminus of the Tpr-Met oncoprotein as a major site of autophosphorylation.
    Kamikura DM, Naujokas MA, Park M.
    Biochemistry; 1996 Jan 23; 35(3):1010-7. PubMed ID: 8547236
    [Abstract] [Full Text] [Related]

  • 15. Characterization of the rearranged tpr-met oncogene breakpoint.
    Dean M, Park M, Vande Woude GF.
    Mol Cell Biol; 1987 Feb 23; 7(2):921-4. PubMed ID: 3821733
    [Abstract] [Full Text] [Related]

  • 16. Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product.
    Furitsu T, Tsujimura T, Tono T, Ikeda H, Kitayama H, Koshimizu U, Sugahara H, Butterfield JH, Ashman LK, Kanayama Y.
    J Clin Invest; 1993 Oct 23; 92(4):1736-44. PubMed ID: 7691885
    [Abstract] [Full Text] [Related]

  • 17. Mechanism of met oncogene activation.
    Park M, Dean M, Cooper CS, Schmidt M, O'Brien SJ, Blair DG, Vande Woude GF.
    Cell; 1986 Jun 20; 45(6):895-904. PubMed ID: 2423252
    [Abstract] [Full Text] [Related]

  • 18. BCL3 rearrangements and t(14;19) in chronic lymphocytic leukemia and other B-cell malignancies: a molecular and cytogenetic study.
    McKeithan TW, Takimoto GS, Ohno H, Bjorling VS, Morgan R, Hecht BK, Dubé I, Sandberg AA, Rowley JD.
    Genes Chromosomes Cancer; 1997 Sep 20; 20(1):64-72. PubMed ID: 9290956
    [Abstract] [Full Text] [Related]

  • 19. BCL2 complex rearrangement in follicular lymphoma: translocation mbr/JH and deletion in the vcr region of the same BCL2 allele.
    Séité P, Hillion J, d'Agay MF, Berger R, Larsen CJ.
    Oncogene; 1993 Nov 20; 8(11):3073-80. PubMed ID: 8414508
    [Abstract] [Full Text] [Related]

  • 20. The t(2;3)(q21;q27) translocation in non-Hodgkin's lymphoma displays BCL6 mutations in the 5' regulatory region and chromosomal breakpoints distant from the gene.
    Chen W, Butler M, Rao PH, Chaganti SR, Louie DC, Dalla-Favera R, Chaganti RS.
    Oncogene; 1998 Oct 01; 17(13):1717-22. PubMed ID: 9796700
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.